Paper Review Records
All Paper Review Records
16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Generation of four human induced pluripotent stem cell lines from dermal fibroblasts of healthy female donor
Lenka Knapova; Marie Valerianova; Sarka Ransdorfova; Radislav Sedlacek; Lenka HromadkovaShow moreShow less
Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec, Czechia; Institute of Hematology and Blood Transfusion, Prague, Czech RepublicShow moreShow less
Generation of autopsy-derived human iPSC lines from 24 sporadic Alzheimer’s disease and control donors characterized for polygenic AD risk
Shannon E. Rose; Adrian Wang; Jennifer Hesson; Alfred Tan; Margaret Sharp-Milgrom; Corbin S.C. Johnson; Mary C. Regier; Harald Frankowski; Annette C. Smith; C. Dirk Keene; Gwenn A. Garden; Paul K. Crane; Elizabeth Blue; Suman Jayadev; Julie Mathieu; Jessica E. YoungShow moreShow less
Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States; Institute of Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, United States; Department of Comparative Medicine, University of Washington, Seattle, WA, United States; Department of Neurology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States; Department of Medicine, University of Washington, Seattle, WA, United States; Department of Medicine, Division Medical Genetics, University of Washington, Seattle, WA, United States; Department of Neurology, University of Washington, Seattle, WA, United StatesShow moreShow less
Generation of a human induced pluripotent stem cell line, PKUHSCi001-A, from a patient with infantile epileptic spasms syndrome carrying a de novo PHF21A variant
Yaming Yang; Ting Wang; Jiao LiuShow moreShow less
Center of Medical and Health Analysis, Peking University Health Science Center, Beijing, China; Children’s Medical Centre of Peking University First Hospital, ChinaShow moreShow less
Generation of a CRISPR/Cas9-corrected isogenic control iPSC line (NIMHi001-A-1) from a Parkinson’s disease Patient-Derived iPSC line carrying the LRRK2 I1371V mutation
Roon Banerjee; Khushboo Singh; Ujaswini Gogoi; Vedam Ramprasad; Gunisha Pasricha; Jiny Nair; Riyanka Kumari; Ravi Yadav; Nitish Kamble; Vikram Holla; Pramod Kumar Pal; Indrani DattaShow moreShow less
Department of Biophysics, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, 560029, India; Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, 560029, India; MedGenome Labs Limited, Bengaluru, 560100, IndiaShow moreShow less
Generation of a PKP2 (c.1171-2 A > G) mutant human embryonic stem cell line using adenine base editing
Hongyu Li; Chang Su; Xinran Bai; Meilan Ma; Wenrui Liu; Youxu Jiang; Jiaqi GaoShow moreShow less
Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; Institute for Health Surveillance Analysis & Protection, Hubei Provincial Center for Disease Control and Prevention, Wuhan 430079, China; Nanchang University Queen Mary School, Nanchang, Jiangxi, China; The Second Clinical Medical School of Zhengzhou University, Zhengzhou, Henan, ChinaShow moreShow less
Generation of a human induced pluripotent stem cell line (ZZUNEUi040-A) from a male patient with hypertrophic cardiomyopathy carrying a heterozygous TPM1 (c.644C > T) mutation
Jianchao Zhang; Rencai Peng; Ningyu Ding; Xiaowei LiShow moreShow less
Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, No. 2 Beijing Anzhen Road, Chaoyang District, Beijing 100029, China; Centre for Cardiovascular Diseases, Henan Key Laboratory of Hereditary Cardiovascular Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou 450052, ChinaShow moreShow less
FAQ
How long does Stem Cell Research take to review a manuscript?
As of 2026-11-19, CrushSCI has 16 complete review records for Stem Cell Research. The fastest paper went from submission to acceptance in 25 days (Establishment of four induced pluripotent stem cell lines (IGIBi028-A, IGIBi029-A, IGIBi030-A, and IGIBi031-A) from peripheral blood derived cells of Spinocerebellar ataxia Type 12 patients, received 2026-07-03, accepted 2026-07-28); the slowest took 329 days. The average is 78.3 days and the median is 52 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
